Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

673 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
L'Oreal : Annual General Meeting and Board of Directors’ meeting of 23 April 2024
PU
Transcript : L'Oréal S.A. - Shareholder/Analyst Call
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST
AQ
Jay L. Schottenstein to Be Inducted into World Retail Hall of Fame
BU
Transcript : Amgen Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 09:10 AM
Transcript : Alector, Inc., 2023 Earnings Call, Feb 27, 2024
2023 Annual Results
GL
Transcript : Neurocrine Biosciences, Inc., Q4 2023 Earnings Call, Feb 07, 2024
Transcript : Eli Lilly and Company, Q4 2023 Earnings Call, Feb 06, 2024
Transcript : Keysight Technologies, Inc. - Special Call
Transcript : Alector, Inc. - Special Call
Transcript : Neurocrine Biosciences, Inc. - Analyst/Investor Day
Transcript : Amgen Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-29-2023 09:10 AM
First Quantum suspends commercial operations at Cobre Panama mine after Panama court declares contract unconstitutional
AQ
Transcript : Vigil Neuroscience, Inc. - Special Call
Transcript : Zymeworks Inc., Q3 2023 Earnings Call, Nov 07, 2023
Transcript : Eli Lilly and Company, Q3 2023 Earnings Call, Nov 02, 2023
Transcript : Karuna Therapeutics, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Transcript : Neurocrine Biosciences, Inc., Q3 2023 Earnings Call, Oct 31, 2023
Transcript : AnaptysBio, Inc. - Special Call
Transcript : Alkermes plc, Q3 2023 Earnings Call, Oct 25, 2023
Kevin McCarthy's wild ride as US House speaker ends in historic fall
RE
14 rue Royale, historical address of L’Oréal Groupe, becomes Le Visionnaire – Espace François Dalle
GL
Transcript : Vigil Neuroscience, Inc. - Special Call
Transcript : Madrigal Pharmaceuticals, Inc. - Special Call
Transcript : AnaptysBio, Inc. - Special Call
Annual General Meeting and Board of Directors' Meeting of 21 April 2023; Renewal of the term of office as Directors of Ms Sophie Bellon and Ms Fabienne Dulac; Dividend of EUR6.00 per share, increased by +25%
AQ
L'Oreal : Annual General Meeting and Board of Directors’ Meeting of 21 April 2023
PU
L'Oreal : Annual General Meeting and Board of Directors’ Meeting of 21 April 2023
PU
Transcript : L'Oréal S.A. - Shareholder/Analyst Call
31 March 2023 : Presentation of the Board of Directors 2023
PU
17 March 2023 : Statutory Auditors’ Special Report on regulated agreements 2022
PU
L'Oreal : The Essentials
PU
L'Oreal : 2022 Universal Registration Document
PU
31 March 2023 : Convening notice
PU
Transcript : Alkermes plc, Q4 2022 Earnings Call, Feb 16, 2023
L'Oreal Finance: 2022 Annual Results
AQ
L'Oréal: News release: "2022 Annual Results"
GL
L'Oréal: News release: "2022 Annual Results"
GL
Transcript : Neurocrine Biosciences, Inc., Q4 2022 Earnings Call, Feb 06, 2023
Transcript : Akero Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 10:30 AM
Transcript : Karuna Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 09:00 AM
Transcript : Horizon Oil Limited - Shareholder/Analyst Call
Transcript : Neurocrine Biosciences, Inc., Q3 2022 Earnings Call, Nov 01, 2022
L'Oréal: News release: "Sales at 30 September 2022"
GL
L'Oréal: News release: "Sales at 30 September 2022"
GL
Inhibrx : CTOS 2022- INBRX-109 Chondrosarcoma expansion cohorts
PU
Inhibrx : CTOS 2022- INBRX-109 Phase 2 Chondrosarcoma TiP
PU
Transcript : Telstra Corporation Limited - Shareholder/Analyst Call
L'Oreal Chairman, Jean-Paul Agon, awarded the 2022 Appeal of Conscience Award
AQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Jean-Paul Agon
  4. News